Acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma: final results from a Phase 2 study

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{bfda490079f247f99c787f30d1e39af3,

title = "Acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma: final results from a Phase 2 study",

author = "\{Joseph Rule\}, Simon",

year = "2021",

month = jun,

day = "17",

doi = "10.1002/hon.58\_2880",

language = "English",

volume = "39",

journal = "Hematological Oncology",

issn = "0278-0232",

publisher = "John Wiley and Sons Ltd",

number = "S2",

}